INSIGHTS ON DRUG DEVELOPMENT

• Take Action On PFAS To Protect Your Critical Processes

  PFAS restrictions are tightening, but a full ban could disrupt critical industries lacking alternatives, such as pharmaceutical manufacturing. Learn where PFAS use remains indispensable.

• Direct Amplification Of Samples Associated With Strawberry Leaf Punches

  Skip extraction and still achieve reliable qPCR results. See how direct amplification of plant samples enables faster workflows, lower costs, and clear detection of resistance markers.

• mTOR Pathway

  Explore the mTOR signaling pathway and reveal how mTORC1 regulates cell growth, metabolism, and survival to ensure cellular function and adaptation to environmental cues.

• Unlock Efficiency: Leverage The Right Tools To Build Process Knowledge

  The biopharma industry must shift from data collection to process knowledge, leveraging digital tools to optimize drug development, enhance quality, and streamline tech transfer through digital maturity.

• Patient-Centric Formulations In Pediatric Adherence

  11/13/2025

  Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

• Integration From Formulation Development To Manufacturing, Packaging

  2/27/2025

  Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.

• Streamlining Cell Line Development For Antibodies

  8/27/2025

  Streamline your antibody production with a robust Cell Line Development strategy. Discover how automation, analytics, and digital tools accelerate development from clone selection to commercialization.

• Strategic Early Material Generation For Accelerated Process Development

  5/14/2026

  Learn how early material generation strategies can accelerate biologics development, streamline process optimization, and enable scalable, production-relevant material supply from the earliest stages of development.

• Highly Sensitive ELISAs In 90 Minutes

  9/11/2024

  Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.